InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: None

Wednesday, 12/06/2017 10:42:04 AM

Wednesday, December 06, 2017 10:42:04 AM

Post# of 1721
FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics

https://tinyurl.com/yal8ofpx

In addition to buprenorphine sublingual spray, INSYS is also developing treatments for a variety of conditions other than pain, including synthetic cannabidiol (CBD) for two types of pediatric epilepsy and Prader-Willi syndrome; dronabinol for anorexia-associated weight loss in cancer and agitation in Alzheimer's disease; buprenorphine/naloxone sublingual spray for opioid dependence; naloxone nasal spray for opioid overdose; epinephrine nasal spray for anaphylaxis; and rizatriptan nasal spray for migraine.

Trump and Obama don't care.

Your senators and representatives, if you have any, don't care.

They get votes from scary panics and a load of lies and people can die in agony for all they care.

No one questions the tragic deaths from street drugs but most of those are very useful medicines that can save lives. Politicians mostly want to save their seats.

You gotta be tough-minded to be politicians and such and not let on to things.

Best, Terry

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.